Moneycontrol
HomeNewscoronavirusNo need to be alarmed immensely over COVID-19 reinfection case reported in Hong Kong: ICMR

No need to be alarmed immensely over COVID-19 reinfection case reported in Hong Kong: ICMR

At a press briefing, the Indian Council of Medical Research (ICMR) Director-General Balram Bhargava said the Hong Kong case is a stray example and the reinfection can depend upon various factors.

August 25, 2020 / 21:33 IST
Story continues below Advertisement

The apex health research body, ICMR, on August 25 said there is "no need to be alarmed immensely" over the reinfection case of COVID-19 reported in Hong Kong, but at the same time maintained that it is not yet known how long the immunity lasts in case of coronavirus.

At a press briefing, the Indian Council of Medical Research (ICMR) Director-General Balram Bhargava said the Hong Kong case is a stray example and the reinfection can depend upon various factors.

Story continues below Advertisement

"We have read with interest the reports of reinfection in one case in Hong Kong. We are learning more and more about the disease as we go ahead. It can depend on several factors, one can be related to the patient itself, how is his immunity, how was his immune status, was it compromised. It can also depend upon the virus, whether the virus has mutated or turned virulent," he said.

However, only one case of re-infection has been reported and it is very rare for viral infections, he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show